Table 1.
Groups | TNF‐α (pg/mg) | IL‐6 (pg/mg) | INF‐γ (pg/mg) |
---|---|---|---|
control | 99.90 ± 3.429 | 10.78 ± 0.1722 | 113.8 ± 8.448 |
LIR | 109.4 ± 7.060 | 11.32 ± 0.2483 | 153.8 ± 3.545 |
AD | 351.6 ± 9.975 a**b** | 19.47 ± 0.4926 a**b** | 453.8 ± 43.34 a**b** |
LIR + AD | 104.3 ± 11.48 c** | 13.30 ± 2.049 a*b*c** | 148.0 ± 4.147 a**b*c** |
Data are mean ± SD (n = 6 for each group). a: control versus AD or LIR + AD, b:LIR versus AD or LIR + AD, c: AD versus LIR + AD. (*≤0.05, **<0.01). (AD = Alzheimer's disease, LIR = liraglutide and LIR + AD = liraglutide + Alzheimer), TNF‐α = tumor necrosis factor, IL‐6 = interleukin 6, and INF‐γ = interferon‐γ.